Citation Impact
Citing Papers
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
2004 StandoutNature
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
mRNA-Based Protein Replacement Therapy for the Heart
2018
Evaluation and stages of surgical innovations
2009 Standout
Hypoxia-Inducible Factor 1-Alpha Reduces Infarction and Attenuates Progression of Cardiac Dysfunction After Myocardial Infarction in the Mouse
2005
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Angiogenesis in health and disease
2003 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Pulmonary thromboendarterectomy surgery
2004
The Current Treatment of Pulmonary Arterial Hypertension
2006
Angiogenesis in life, disease and medicine
2005 StandoutNature
Challenges in evaluating surgical innovation
2009
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension
2004
Molecular Biology of Chronic Thromboembolic Pulmonary Hypertension
2006
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Molecular regulation of vessel maturation
2003 Standout
Frailty: implications for clinical practice and public health
2019 Standout
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
Pulmonary Arterial Hypertension
2004
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension
2006
Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients
2012
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases
2003
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
2008
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
2009
Chronic thromboembolic pulmonary hypertension
2014
Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension
2006
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension
2004
Pulmonary Arterial Hypertension
2006
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension
2003
A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In Vivo
2009 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Preoperative Frailty Assessment and Outcomes at 6 Months or Later in Older Adults Undergoing Cardiac Surgical Procedures
2016
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
The angiopietin-1–Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice
2009
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Diagnosis and Treatment of Secondary (Non–Category 1) Pulmonary Hypertension
2008
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Current Management of Calcific Aortic Stenosis
2013
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
2005
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Pathobiology of Pulmonary Hypertension
2007
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Stabilized HIF‐1α is superior to VEGF for angiogenesis in skeletal muscle via adeno‐associated virus gene transfer
2005
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Signaling and Functions of Angiopoietin-1 in Vascular Protection
2006
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Works of Danny Chu being referenced
Gene Delivery to the Mammalian Heart Using AAV Vectors
2004
A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1
2004
Signaling Molecules in Nonfamilial Pulmonary Hypertension
2003
Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors
2003
Does the Level of Experience of Residents Affect Outcomes of Coronary Artery Bypass Surgery?
2009
Severe Aortic Stenosis in a Veteran Population: Treatment Considerations and Survival
2010
Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population
2012
Video-Assisted Thoracoscopic Versus Open Thoracotomy Lobectomy in a Cohort of 13,619 Patients
2010
Entecavir safety and effectiveness in a national cohort of treatment‐naïve chronic hepatitis B patients in the US – the ENUMERATE study
2015
Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway
2003